Efficacy of Hydroxyurea in Providing Transfusion Independence in β-Thalassemia

201146 citationsJournal Article

Authors

Saqib Hussain Ansari · National Institute Of Blood Disease and Bone Marrow Transplantation

Tahir Shamsi · National Institute Of Blood Disease and Bone Marrow Transplantation

Mushtaq Ashraf · National Institute Of Blood Disease and Bone Marrow Transplantation

Kousar Perveen · National Institute Of Blood Disease and Bone Marrow Transplantation

Tasneem Farzana · National Institute Of Blood Disease and Bone Marrow Transplantation

Muneera Bohray · National Institute Of Blood Disease and Bone Marrow Transplantation

Abstract

HU was found to be safe in patients with β-thalassemia major, and resulted in the reduction of transfusion requirement and in an increase in the interval between transfusions.

Topics & Keywords

Hemoglobinopathies and Related Disorders Iron Metabolism and Disorders Blood donation and transfusion practices

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Pediatric Hematology/Oncology

Volume 33, Issue 5, pp. 339-343

DOI: 10.1097/mph.0b013e31821b0770

Field-Weighted Citation Impact: 1.05